Chemicals and pharmaceuticals · ECL

ECOLAB INC.

12 filings mentioning 6 of the compliance and risk topics we track. Every row links to the filing on EDGAR.

12filings we hold
6topics disclosed
Chemicals and pharmaceuticalsindustry
MNbased in

Across 12 filings we hold, ECOLAB INC. has written down 6 of the topics we track. That places it 2 of 7 companies we hold in chemicals and pharmaceuticals, by how much we have collected.

ECL Chemicals and pharmaceuticals

What this obligates

Every instrument in our corpus that governs something ECOLAB INC. has written into a filing. Not what they said. What applies once they have said it.

ISO/IEC 42001:202361
ISO 27001:202242
NIST AI Risk Management Framework (AI RMF 1.0)41
GDPR26
ISO/IEC 27701:201921
DORA19
Colorado Artificial Intelligence Act (proposed SB 24-205)16
EU AI Act15
NIST SP 800-16115
Code of Conduct on Data Protection for Research (GDPR Article 40)12

10 frameworks, 268 controls between them, deduplicated across topics.

What it discloses

Tracked topics appearing in this company's filings, most frequent first.

Bars are scaled against this company's most frequent topic, not against the market. The table below has the exact counts.

TopicFilingsMost recent
Internal Control122026-05-29
Material Weakness112026-05-29
Artificial Intelligence92026-02-10
Third Party Risk Management32026-02-23
Restatement22025-03-28
Data Breach12019-12-23

When it filed

Filings we hold, by year. Hover a bar for the count.

19
20
21
22
23
24
25
26

Recent filings

FiledFormItem
2026-05-298-KOther material event, Financial statements and exhibitsfiling
2026-02-2310-Kfiling
2026-02-108-KResults of operations, the earnings release, Item 2.05, Financial statements and exhibitsfiling
2025-10-288-KResults of operations, the earnings release, Financial statements and exhibitsfiling
2025-08-278-KOther material event, Financial statements and exhibitsfiling
2025-07-298-KResults of operations, the earnings release, Financial statements and exhibitsfiling
2025-06-058-KOther material event, Financial statements and exhibitsfiling
2025-04-298-KResults of operations, the earnings release, Financial statements and exhibitsfiling
2025-03-288-KEntry into a material agreement, Item 2.03, Financial statements and exhibitsfiling
2025-02-2110-Kfiling
2025-02-118-KResults of operations, the earnings release, Financial statements and exhibitsfiling
2024-10-298-KResults of operations, the earnings release, Financial statements and exhibitsfiling

Others in chemicals and pharmaceuticals

The companies we hold most on in the same industry. Each opens side by side with this one.

New here? Signals tracks the compliance and risk language public companies put into their SEC filings, and cross-references it against 723 frameworks and 20,473 controls. See what moved today or check how much of a framework you already cover.

What this page is

Every row comes from SEC full-text search over this company's filings, matched against the compliance and risk phrases we track. It is a record of what the company itself wrote down in documents it is legally accountable for. It is not an assessment of the company, a rating, or a claim about how well it manages anything.

A phrase appearing in a filing frequently means the risk section mentions it, not that an event occurred. Where an item number indicates an actual event, the Item column says so.

All of chemicals and pharmaceuticals · All companies · Today's edition